|
Fibrinolysis
Citations 51-60 of 146 total displayed.
|
Past content
(since Jan 1999):
|
- Vascular Medicine
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials
- Susan Wan, Daniel J. Quinlan, Giancarlo Agnelli, and John W. Eikelboom
Circulation 2004;110:744-749; published online before print as doi:10.1161/01.CIR.0000137826.09715.9C
[Abstract]
[Full text]
- Articles
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism. A Meta-Analysis of the Randomized Controlled Trials
- Susan Wan, Daniel J. Quinlan, Giancarlo Agnelli, and John W. Eikelboom
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000137826.09715.9C
[Abstract]
- Review: Current Perspective
Bidirectional Relation Between Inflammation and Coagulation
- Marcel Levi, Tom van der Poll, and Harry R. Büller
Circulation 2004;109:2698-2704, doi:10.1161/01.CIR.0000131660.51520.9A
[Full text]
- Review: Clinical Cardiology: New Frontiers
Pharmacoinvasive Therapy: The Future of Treatment for ST-Elevation Myocardial Infarction
- Elliott M. Antman and Frans Van de Werf
Circulation 2004;109:2480-2486, doi:10.1161/01.CIR.0000128736.57259.48
[Full text]
- Correspondence
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty • Response
- Roberto Manfredini, Benedetta Boari, Philippe Gabriel Steg, Eric Bonnefoy, Paul Touboul, Sylvie Chabaud, Alain Leizorovicz, Frédéric Lapostolle, Pierre-Yves Dubien, and Pascal Cristofini
Circulation 2004;109:e219, doi:10.1161/01.CIR.0000127696.00202.67
[Full text]
- Basic Science Reports
Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death
- Aaron E. Cozen, Hideaki Moriwaki, Michal Kremen, Mary Beth DeYoung, Helén L. Dichek, Katherine I. Slezicki, Stephen G. Young, Murielle Véniant, and David A. Dichek
Circulation 2004;109:2129-2135; published online before print as doi:10.1161/01.CIR.0000127369.24127.03
[Abstract]
[Full text]
- Correspondence
Why Did the Anti-C5 Complement Antibody Pexelizumab Not Reduce Infarct Size but Influence Clinical Outcomes Positively When Applied as Adjunctive Therapy to Primary Percutaneous Coronary Intervention? • Response
- Jiri T. Beranek, Christopher B. Granger, Kenneth W. Mahaffey, W. Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Thomas G. Todaro, Scott Rollins, Christopher F. Mojcik, Jose C. Nicolau, Witold Ruzyllo, and Paul W. Armstrong
Circulation 2004;109:e195-196e, doi:10.1161/01.CIR.0000127111.19811.F9
[Full text]
- Articles
Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death
- Aaron E. Cozen, Hideaki Moriwaki, Michal Kremen, Mary Beth DeYoung, Helén L. Dichek, Katherine I. Slezicki, Stephen G. Young, Murielle Véniant, and David A. Dichek
Circulation published April 19, 2004, doi:10.1161/01.CIR.0000127369.24127.03
[Abstract]
- Correspondence
Influence of Time to Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis • Response
- Peter Elsman, Freek W.A. Verheugt, Evert J.P. Lamfers, Albert Schömig, Gjin Ndrepepa, Julinda Mehilli, Markus Schwaiger, Helmut Schühlen, Stephan Nekolla, Jürgen Pache, Stefan Martinoff, Hildegard Bollwein, and Adnan Kastrati
Circulation 2004;109:e68, doi:10.1161/01.CIR.0000116534.44062.B2
[Full text]
- Correspondence
Fibrinolytic Therapy: What Size to Fit All? • Response
- Mario Ivanu
 a, Paul W. Armstrong, Désiré Collen, and Elliott Antman
Circulation 2003;108:e170, doi:10.1161/01.CIR.0000108167.21070.15
[Full text]
|
|
